Rockwell Medical, Inc., a healthcare company specializing in hemodialysis products, has entered a three-year partnership agreement with Innovative Renal Care (IRC), one of the largest dialysis service providers in the U.S. The agreement ensures the reliable supply of high-quality hemodialysis concentrates to IRC's clinics, focusing on streamlining workflows and preventing supply chain disruptions. Rockwell Medical will provide IRC with both liquid and dry acid and bicarbonate concentrates, including the DAMX45 dry acid concentrate mix system, enhancing storage efficiency and product continuity. The multi-million dollar agreement includes utilization commitments and an option to extend for an additional year.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rockwell Medical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250708397524) on July 08, 2025, and is solely responsible for the information contained therein.